Moneycontrol
Last Updated : Apr 17, 2018 12:59 PM IST | Source: Moneycontrol.com

Cipla Q4 PAT seen up 57.7% YoY to Rs. 322 cr: Edelweiss

Net Sales are expected to increase by 6.2 percent Y-o-Y (down 2.8 percent Q-o-Q) to Rs. 3,805.3 crore, according to Edelweiss.

Moneycontrol News @moneycontrolcom
 
 
live
  • bselive
  • nselive
Volume
Todays L/H
More

Edelweiss has come out with its fourth quarter (Jan-March’ 18) earnings estimates for the Pharma sector. The brokerage house expects Cipla to report net profit at Rs. 322 crore up 57.7% year-on-year (down 16% quarter-on-quarter).


Net Sales are expected to increase by 6.2 percent Y-o-Y (down 2.8 percent Q-o-Q) to Rs. 3,805.3 crore, according to Edelweiss.


Earnings before interest, tax, depreciation and amortisation (EBITDA) are likely to rise by 30 percent Y-o-Y (down 19.6 percent Q-o-Q) to Rs. 657.9 crore.


Disclaimer: The views and investment tips expressed by investment experts on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.

First Published on Apr 16, 2018 05:58 pm
Loading...
Sections
Follow us on
Available On
PCI DSS Compliant